home / stock / tsvt / tsvt quote
Last: | $4.255 |
---|---|
Change Percent: | 0.93% |
Open: | $4.25 |
Close: | $4.255 |
High: | $4.3788 |
Low: | $4.135 |
Volume: | 311,012 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.255 | $4.25 | $4.255 | $4.3788 | $4.135 | 311,012 | 04-26-2024 |
$4.29 | $4 | $4.29 | $4.3497 | $3.44 | 3,725,775 | 04-25-2024 |
$4.27 | $4.63 | $4.27 | $4.7389 | $4.21 | 469,810 | 04-24-2024 |
$4.63 | $4.65 | $4.63 | $4.86 | $4.595 | 291,752 | 04-23-2024 |
$4.65 | $4.55 | $4.65 | $4.72 | $4.345 | 406,373 | 04-22-2024 |
$4.52 | $4.61 | $4.52 | $4.7599 | $4.455 | 608,644 | 04-19-2024 |
$4.64 | $5.01 | $4.64 | $5.0699 | $4.61 | 714,023 | 04-18-2024 |
$5.06 | $4.91 | $5.06 | $5.2002 | $4.87 | 896,008 | 04-17-2024 |
$4.86 | $4.99 | $4.86 | $4.99 | $4.7 | 932,484 | 04-16-2024 |
$4.985 | $4.97 | $4.985 | $5.12 | $4.9501 | 393,377 | 04-15-2024 |
$5.04 | $5.47 | $5.04 | $5.495 | $4.9615 | 797,617 | 04-12-2024 |
$5.52 | $5.21 | $5.52 | $5.52 | $5.11 | 713,131 | 04-11-2024 |
$5.23 | $5.4 | $5.23 | $5.5 | $5.1866 | 855,967 | 04-10-2024 |
$5.63 | $5.48 | $5.63 | $5.81 | $5.46 | 1,351,334 | 04-09-2024 |
$5.51 | $5.25 | $5.51 | $5.7199 | $5.05 | 1,718,737 | 04-08-2024 |
$4.92 | $5.41 | $4.92 | $5.9 | $4.915 | 4,392,047 | 04-05-2024 |
$5.01 | $5.04 | $5.01 | $5.12 | $4.91 | 482,867 | 04-04-2024 |
$4.98 | $4.96 | $4.98 | $5.16 | $4.7802 | 621,792 | 04-03-2024 |
$4.94 | $5.64 | $4.94 | $5.7 | $4.93 | 1,082,439 | 04-02-2024 |
$5.79 | $5.53 | $5.79 | $5.99 | $5.39 | 1,248,111 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
2seventy bio Inc. Company Name:
TSVT Stock Symbol:
NASDAQ Market:
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings??...
2024-04-08 00:00:02 ET Citigroup analyst issues BUY recommendation for TSVT on April 7, 2024 04:22PM ET. The previous analyst recommendation was Buy. TSVT was trading at $4.92 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
Friday, the FDA approved Bristol-Myers Squibb Company (NYSE:BMY) and 2seventy Bio Inc’s (NASDAQ:TSVT) Abecma&n...